Sources | Names Used |
---|---|
CTRPv2 | erlotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | erlotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MYO1E | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
mRNA | PLP1 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-05 |
mRNA | FXYD3 | CTRPv2 | pan-cancer | AAC | 0.18 | 3e-05 |
mRNA | SERPINB4 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | WDR62 | CTRPv2 | pan-cancer | AAC | -0.16 | 3e-05 |
mRNA | SNRPB2 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
mRNA | HHAT | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
mRNA | CH17-270A2.2 | CTRPv2 | pan-cancer | AAC | -0.17 | 3e-05 |
mRNA | ACSS2 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-05 |
mRNA | MELTF | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |